Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X026485 | — |
no adverse event; Inbound call from HCP to report AE for VAQTA. HCP noted that a dose of expired VAQTA was inadvertently administered to a patient. No symptomatic events were reported. Information regarding supported dose of VAQTA was provided via post-memo article. N; This spontaneous report was received from a Pharmacist and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 06-Jun-2025, the patient started therapy with Hepatitis A Vaccine, Inactivated Injection(VAQTA) (lot #X026485, expiration date: 11-May-2025)(a dose of expired VAQTA was inadvertently administered to a patient). No symptomatic events were reported.